Barbara Stranger
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 19 | 2023 | 431 | 2.590 |
Why?
| | Quantitative Trait Loci | 25 | 2021 | 388 | 2.390 |
Why?
| | Genome-Wide Association Study | 27 | 2025 | 1537 | 2.350 |
Why?
| | Genetic Variation | 24 | 2021 | 996 | 2.240 |
Why?
| | Sex Characteristics | 11 | 2026 | 801 | 1.980 |
Why?
| | Gene Expression Regulation | 24 | 2020 | 2599 | 1.950 |
Why?
| | Polymorphism, Single Nucleotide | 36 | 2025 | 2240 | 1.430 |
Why?
| | Models, Genetic | 6 | 2023 | 540 | 1.290 |
Why?
| | Transcriptome | 14 | 2025 | 1068 | 1.200 |
Why?
| | Multifactorial Inheritance | 5 | 2023 | 243 | 1.130 |
Why?
| | Genomics | 13 | 2019 | 853 | 0.990 |
Why?
| | Gene Expression Profiling | 20 | 2023 | 1792 | 0.840 |
Why?
| | Genetic Predisposition to Disease | 19 | 2025 | 2488 | 0.750 |
Why?
| | Obsessive-Compulsive Disorder | 2 | 2025 | 60 | 0.750 |
Why?
| | Gene Expression | 5 | 2020 | 1463 | 0.730 |
Why?
| | Software | 5 | 2017 | 676 | 0.700 |
Why?
| | Regulatory Sequences, Nucleic Acid | 6 | 2012 | 90 | 0.650 |
Why?
| | Sex Factors | 6 | 2025 | 2107 | 0.640 |
Why?
| | Genetics, Population | 10 | 2015 | 226 | 0.610 |
Why?
| | Phenotype | 13 | 2023 | 3206 | 0.550 |
Why?
| | DNA Copy Number Variations | 3 | 2015 | 192 | 0.510 |
Why?
| | Alternative Splicing | 3 | 2018 | 253 | 0.480 |
Why?
| | Neuroblastoma | 4 | 2019 | 177 | 0.470 |
Why?
| | Autoimmune Diseases | 4 | 2014 | 467 | 0.440 |
Why?
| | Transcription Initiation Site | 3 | 2012 | 43 | 0.430 |
Why?
| | Precision Medicine | 1 | 2019 | 462 | 0.420 |
Why?
| | Disease | 3 | 2020 | 97 | 0.400 |
Why?
| | Selection, Genetic | 8 | 2013 | 269 | 0.390 |
Why?
| | beta-Thalassemia | 1 | 2014 | 40 | 0.390 |
Why?
| | Genetic Loci | 4 | 2025 | 273 | 0.390 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2014 | 93 | 0.370 |
Why?
| | Systems Biology | 1 | 2012 | 68 | 0.350 |
Why?
| | Myelodysplastic Syndromes | 1 | 2014 | 170 | 0.340 |
Why?
| | Humans | 73 | 2026 | 146342 | 0.330 |
Why?
| | Haplotypes | 10 | 2013 | 506 | 0.320 |
Why?
| | Mental Disorders | 1 | 2019 | 1148 | 0.300 |
Why?
| | Gene Dosage | 2 | 2007 | 146 | 0.300 |
Why?
| | Chromosome Mapping | 7 | 2018 | 508 | 0.270 |
Why?
| | Databases, Genetic | 4 | 2018 | 239 | 0.270 |
Why?
| | Gene-Environment Interaction | 2 | 2023 | 190 | 0.260 |
Why?
| | Arabidopsis | 2 | 2005 | 99 | 0.240 |
Why?
| | Male | 27 | 2026 | 73396 | 0.230 |
Why?
| | Organ Specificity | 3 | 2020 | 307 | 0.230 |
Why?
| | Female | 27 | 2026 | 79499 | 0.220 |
Why?
| | Arthritis, Rheumatoid | 5 | 2015 | 1185 | 0.220 |
Why?
| | Biomarkers, Tumor | 2 | 2025 | 1339 | 0.220 |
Why?
| | Multiple Sclerosis | 3 | 2023 | 435 | 0.220 |
Why?
| | Glycoside Hydrolases | 1 | 2005 | 38 | 0.210 |
Why?
| | Alleles | 9 | 2015 | 907 | 0.210 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 71 | 0.210 |
Why?
| | Arabidopsis Proteins | 1 | 2005 | 78 | 0.200 |
Why?
| | Biological Evolution | 2 | 2021 | 471 | 0.200 |
Why?
| | Case-Control Studies | 7 | 2025 | 3647 | 0.200 |
Why?
| | Lymphocytes | 2 | 2020 | 379 | 0.200 |
Why?
| | Linkage Disequilibrium | 6 | 2013 | 260 | 0.190 |
Why?
| | Host-Pathogen Interactions | 2 | 2018 | 366 | 0.190 |
Why?
| | Quality Control | 1 | 2023 | 163 | 0.190 |
Why?
| | RNA | 3 | 2019 | 926 | 0.190 |
Why?
| | DNA | 2 | 2006 | 1421 | 0.190 |
Why?
| | Multiple Myeloma | 1 | 2026 | 310 | 0.180 |
Why?
| | Epigenomics | 2 | 2019 | 124 | 0.180 |
Why?
| | Chromosomes, Human, X | 2 | 2020 | 76 | 0.170 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 154 | 0.170 |
Why?
| | Guidelines as Topic | 1 | 2023 | 267 | 0.170 |
Why?
| | Telomere Shortening | 1 | 2020 | 20 | 0.160 |
Why?
| | Cell Line | 6 | 2017 | 2814 | 0.160 |
Why?
| | Telomere Homeostasis | 1 | 2020 | 35 | 0.160 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 747 | 0.160 |
Why?
| | Glioma | 1 | 2025 | 425 | 0.160 |
Why?
| | Tumor Suppressor Proteins | 2 | 2020 | 315 | 0.150 |
Why?
| | Influenza A virus | 2 | 2018 | 120 | 0.150 |
Why?
| | Genotype | 6 | 2016 | 1879 | 0.150 |
Why?
| | Mutation | 3 | 2026 | 4093 | 0.150 |
Why?
| | 5-Methylcytosine | 1 | 2019 | 24 | 0.150 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2014 | 1150 | 0.150 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2019 | 40 | 0.140 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 63 | 0.140 |
Why?
| | Molecular Sequence Annotation | 2 | 2018 | 110 | 0.140 |
Why?
| | Monocytes | 3 | 2019 | 538 | 0.140 |
Why?
| | Aminopeptidases | 1 | 2018 | 20 | 0.140 |
Why?
| | Receptors, Glutamate | 1 | 2018 | 27 | 0.140 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2026 | 1432 | 0.140 |
Why?
| | Transcription, Genetic | 3 | 2017 | 1432 | 0.140 |
Why?
| | Immune System | 1 | 2019 | 181 | 0.140 |
Why?
| | Alzheimer Disease | 3 | 2014 | 641 | 0.130 |
Why?
| | Autoimmunity | 2 | 2014 | 925 | 0.130 |
Why?
| | Pharmacogenetics | 1 | 2019 | 176 | 0.130 |
Why?
| | Diabetic Retinopathy | 1 | 2020 | 211 | 0.130 |
Why?
| | N-Myc Proto-Oncogene Protein | 1 | 2017 | 11 | 0.130 |
Why?
| | Promoter Regions, Genetic | 2 | 2020 | 1242 | 0.130 |
Why?
| | Cerebral Cortex | 1 | 2021 | 485 | 0.130 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 286 | 0.130 |
Why?
| | Gene Amplification | 1 | 2017 | 116 | 0.130 |
Why?
| | Proto-Oncogene Proteins | 1 | 2020 | 616 | 0.130 |
Why?
| | Aging | 2 | 2020 | 1996 | 0.130 |
Why?
| | Telomere | 1 | 2020 | 300 | 0.120 |
Why?
| | Genetic Markers | 2 | 2020 | 340 | 0.120 |
Why?
| | DNA Methylation | 2 | 2019 | 725 | 0.120 |
Why?
| | HapMap Project | 2 | 2017 | 4 | 0.120 |
Why?
| | Nucleic Acid Hybridization | 2 | 2007 | 175 | 0.120 |
Why?
| | Computational Biology | 5 | 2021 | 678 | 0.120 |
Why?
| | Neoplasms, Second Primary | 1 | 2016 | 103 | 0.110 |
Why?
| | HLA-G Antigens | 1 | 2015 | 2 | 0.110 |
Why?
| | Cell Line, Tumor | 5 | 2026 | 3545 | 0.110 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 712 | 0.110 |
Why?
| | Brain Neoplasms | 1 | 2025 | 1325 | 0.110 |
Why?
| | Immunogenetic Phenomena | 1 | 2015 | 8 | 0.110 |
Why?
| | Immune System Diseases | 1 | 2015 | 43 | 0.110 |
Why?
| | Data Interpretation, Statistical | 2 | 2015 | 368 | 0.110 |
Why?
| | Glucose | 1 | 2020 | 1053 | 0.110 |
Why?
| | Genes | 1 | 2015 | 215 | 0.110 |
Why?
| | Dendritic Cells | 2 | 2018 | 509 | 0.110 |
Why?
| | Evolution, Molecular | 3 | 2007 | 502 | 0.100 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2014 | 6 | 0.100 |
Why?
| | Metabolic Diseases | 1 | 2015 | 114 | 0.100 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 1149 | 0.100 |
Why?
| | Sialic Acid Binding Ig-like Lectin 3 | 1 | 2013 | 10 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2019 | 762 | 0.100 |
Why?
| | STAT Transcription Factors | 1 | 2014 | 25 | 0.100 |
Why?
| | Base Sequence | 5 | 2013 | 2123 | 0.100 |
Why?
| | Myocardium | 1 | 2019 | 948 | 0.100 |
Why?
| | Th17 Cells | 1 | 2014 | 103 | 0.100 |
Why?
| | Leukocytes | 1 | 2015 | 301 | 0.100 |
Why?
| | Antigens, CD | 2 | 2015 | 560 | 0.100 |
Why?
| | Oligonucleotides, Antisense | 1 | 2014 | 122 | 0.100 |
Why?
| | Biomarkers, Pharmacological | 1 | 2013 | 26 | 0.100 |
Why?
| | Neanderthals | 1 | 2013 | 13 | 0.100 |
Why?
| | HLA-DRB1 Chains | 1 | 2013 | 109 | 0.090 |
Why?
| | Major Histocompatibility Complex | 1 | 2013 | 234 | 0.090 |
Why?
| | Survivors | 1 | 2016 | 526 | 0.090 |
Why?
| | Trophoblasts | 1 | 2015 | 219 | 0.090 |
Why?
| | Drug Discovery | 1 | 2013 | 154 | 0.090 |
Why?
| | Sequence Deletion | 1 | 2013 | 190 | 0.090 |
Why?
| | Animals | 9 | 2023 | 38107 | 0.090 |
Why?
| | Influenza, Human | 1 | 2018 | 640 | 0.090 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2020 | 3930 | 0.090 |
Why?
| | Neurodegenerative Diseases | 1 | 2014 | 147 | 0.090 |
Why?
| | Gene Frequency | 4 | 2017 | 496 | 0.090 |
Why?
| | Adult | 9 | 2025 | 41087 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2014 | 303 | 0.090 |
Why?
| | Celiac Disease | 1 | 2014 | 285 | 0.080 |
Why?
| | Chromatin | 2 | 2012 | 559 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2013 | 447 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2014 | 415 | 0.080 |
Why?
| | Lymphocyte Activation | 1 | 2014 | 1137 | 0.080 |
Why?
| | Biomedical Research | 1 | 2017 | 729 | 0.080 |
Why?
| | Algorithms | 3 | 2021 | 1849 | 0.080 |
Why?
| | Protein Interaction Maps | 3 | 2017 | 54 | 0.080 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2016 | 702 | 0.070 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2009 | 18 | 0.070 |
Why?
| | Nervous System Diseases | 1 | 2012 | 288 | 0.070 |
Why?
| | GTP-Binding Proteins | 1 | 2010 | 150 | 0.070 |
Why?
| | Hypoxia | 1 | 2016 | 1211 | 0.070 |
Why?
| | Epistasis, Genetic | 1 | 2008 | 67 | 0.070 |
Why?
| | Genetic Association Studies | 3 | 2016 | 379 | 0.070 |
Why?
| | Geography | 2 | 2007 | 187 | 0.070 |
Why?
| | Dosage Compensation, Genetic | 1 | 2007 | 12 | 0.070 |
Why?
| | Open Reading Frames | 1 | 2008 | 130 | 0.070 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2007 | 28 | 0.070 |
Why?
| | Prognosis | 3 | 2025 | 4351 | 0.070 |
Why?
| | Zebrafish | 1 | 2011 | 536 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2838 | 0.060 |
Why?
| | Gene Duplication | 1 | 2007 | 67 | 0.060 |
Why?
| | Microarray Analysis | 1 | 2007 | 117 | 0.060 |
Why?
| | Genetic Testing | 2 | 2021 | 492 | 0.060 |
Why?
| | Breast Neoplasms | 3 | 2015 | 2418 | 0.060 |
Why?
| | Crohn Disease | 1 | 2010 | 250 | 0.060 |
Why?
| | Polymorphism, Genetic | 2 | 2005 | 612 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2005 | 64 | 0.060 |
Why?
| | Gene Deletion | 1 | 2007 | 385 | 0.060 |
Why?
| | Genetic Linkage | 1 | 2005 | 271 | 0.050 |
Why?
| | Incidence | 2 | 2026 | 2936 | 0.050 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2005 | 157 | 0.050 |
Why?
| | Regression Analysis | 1 | 2007 | 999 | 0.050 |
Why?
| | Young Adult | 5 | 2020 | 14330 | 0.050 |
Why?
| | Sequence Alignment | 1 | 2005 | 360 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2007 | 430 | 0.050 |
Why?
| | Demography | 1 | 2005 | 274 | 0.050 |
Why?
| | Pedigree | 1 | 2005 | 512 | 0.050 |
Why?
| | Sequence Analysis, DNA | 3 | 2013 | 771 | 0.050 |
Why?
| | RNA, Messenger | 4 | 2014 | 2791 | 0.050 |
Why?
| | Cytochrome P-450 CYP1A2 | 1 | 2023 | 8 | 0.050 |
Why?
| | Microsomes, Liver | 1 | 2023 | 85 | 0.050 |
Why?
| | Histones | 3 | 2015 | 670 | 0.050 |
Why?
| | Conserved Sequence | 3 | 2007 | 242 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1031 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2015 | 426 | 0.040 |
Why?
| | Inflammation | 1 | 2013 | 2919 | 0.040 |
Why?
| | Immunity, Innate | 2 | 2019 | 844 | 0.040 |
Why?
| | Central Nervous System | 1 | 2023 | 278 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2020 | 137 | 0.040 |
Why?
| | Risk | 2 | 2014 | 920 | 0.040 |
Why?
| | Cells | 1 | 2020 | 24 | 0.040 |
Why?
| | Mendelian Randomization Analysis | 1 | 2020 | 68 | 0.040 |
Why?
| | Pan troglodytes | 2 | 2013 | 62 | 0.040 |
Why?
| | Organ Size | 1 | 2021 | 465 | 0.040 |
Why?
| | DNA Primers | 2 | 2011 | 487 | 0.040 |
Why?
| | Exons | 2 | 2013 | 361 | 0.040 |
Why?
| | Cytochrome P-450 CYP1A1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 46 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2023 | 630 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 728 | 0.040 |
Why?
| | Gene Ontology | 1 | 2018 | 55 | 0.040 |
Why?
| | Protein Structure, Tertiary | 2 | 2013 | 834 | 0.030 |
Why?
| | Neoplasms | 1 | 2014 | 2954 | 0.030 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 174 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2016 | 3416 | 0.030 |
Why?
| | Interferons | 1 | 2019 | 186 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2012 | 2623 | 0.030 |
Why?
| | Warfarin | 1 | 2019 | 179 | 0.030 |
Why?
| | Interferon Type I | 1 | 2018 | 147 | 0.030 |
Why?
| | Human Genome Project | 1 | 2017 | 15 | 0.030 |
Why?
| | Species Specificity | 2 | 2011 | 543 | 0.030 |
Why?
| | Computer Simulation | 1 | 2021 | 1014 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 693 | 0.030 |
Why?
| | Coronary Artery Bypass | 1 | 2019 | 269 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 752 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2016 | 39 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 441 | 0.030 |
Why?
| | Heterozygote | 2 | 2007 | 311 | 0.030 |
Why?
| | Pilot Projects | 2 | 2016 | 1888 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 360 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2017 | 410 | 0.030 |
Why?
| | Logistic Models | 2 | 2012 | 2126 | 0.030 |
Why?
| | Normal Distribution | 1 | 2015 | 22 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 387 | 0.030 |
Why?
| | Sample Size | 1 | 2015 | 124 | 0.030 |
Why?
| | Information Dissemination | 1 | 2017 | 226 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 22557 | 0.030 |
Why?
| | Rheumatic Fever | 1 | 2014 | 6 | 0.030 |
Why?
| | Probability | 1 | 2015 | 309 | 0.030 |
Why?
| | DNA Repair | 1 | 2016 | 255 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 970 | 0.030 |
Why?
| | Anticoagulants | 1 | 2019 | 746 | 0.030 |
Why?
| | Infant | 2 | 2019 | 10114 | 0.030 |
Why?
| | Multigene Family | 1 | 2014 | 210 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 79 | 0.020 |
Why?
| | Drug Repositioning | 1 | 2013 | 41 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1271 | 0.020 |
Why?
| | Interferon-beta | 1 | 2014 | 90 | 0.020 |
Why?
| | Signaling Lymphocytic Activation Molecule Family | 1 | 2013 | 7 | 0.020 |
Why?
| | HLA-DP beta-Chains | 1 | 2013 | 88 | 0.020 |
Why?
| | Etanercept | 1 | 2013 | 60 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1331 | 0.020 |
Why?
| | Child, Preschool | 2 | 2019 | 11913 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2019 | 611 | 0.020 |
Why?
| | Adaptive Immunity | 1 | 2014 | 173 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2013 | 162 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2016 | 1488 | 0.020 |
Why?
| | Receptor, EphA1 | 1 | 2012 | 2 | 0.020 |
Why?
| | Monomeric Clathrin Assembly Proteins | 1 | 2012 | 5 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2013 | 391 | 0.020 |
Why?
| | Up-Regulation | 1 | 2015 | 841 | 0.020 |
Why?
| | Comparative Genomic Hybridization | 1 | 2011 | 28 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2013 | 207 | 0.020 |
Why?
| | Cell Lineage | 1 | 2014 | 377 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 2014 | 259 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1468 | 0.020 |
Why?
| | Communicable Diseases | 1 | 2014 | 166 | 0.020 |
Why?
| | Hematologic Neoplasms | 1 | 2013 | 170 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2012 | 146 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1543 | 0.020 |
Why?
| | Macrophages | 1 | 2019 | 1532 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2014 | 750 | 0.020 |
Why?
| | Models, Biological | 1 | 2018 | 1761 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 457 | 0.020 |
Why?
| | Risk Factors | 2 | 2016 | 10921 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2014 | 677 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 861 | 0.020 |
Why?
| | INDEL Mutation | 1 | 2010 | 21 | 0.020 |
Why?
| | Antirheumatic Agents | 1 | 2013 | 309 | 0.020 |
Why?
| | Age of Onset | 1 | 2012 | 558 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2113 | 0.020 |
Why?
| | Allelic Imbalance | 1 | 2009 | 8 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 2014 | 419 | 0.020 |
Why?
| | Escherichia coli | 1 | 2014 | 832 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2010 | 168 | 0.020 |
Why?
| | Mice | 2 | 2019 | 18297 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 429 | 0.020 |
Why?
| | Phylogeny | 1 | 2013 | 924 | 0.020 |
Why?
| | Middle Aged | 3 | 2018 | 36619 | 0.020 |
Why?
| | United Kingdom | 1 | 2010 | 377 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2013 | 901 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 6077 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 6034 | 0.020 |
Why?
| | Child | 2 | 2019 | 22693 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3926 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1224 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 2009 | 190 | 0.020 |
Why?
| | Edar Receptor | 1 | 2007 | 1 | 0.020 |
Why?
| | Genes, X-Linked | 1 | 2007 | 21 | 0.020 |
Why?
| | X Chromosome Inactivation | 1 | 2007 | 25 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6460 | 0.020 |
Why?
| | Models, Statistical | 1 | 2012 | 669 | 0.020 |
Why?
| | Chromosomes, Human, Y | 1 | 2007 | 36 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 974 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 699 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2008 | 297 | 0.020 |
Why?
| | Antiporters | 1 | 2007 | 22 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4118 | 0.020 |
Why?
| | Parkinson Disease | 1 | 2014 | 614 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2013 | 1130 | 0.020 |
Why?
| | Homozygote | 1 | 2007 | 197 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2007 | 139 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3712 | 0.020 |
Why?
| | Macaca | 1 | 2007 | 66 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2012 | 740 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2014 | 972 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 2502 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2008 | 369 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2081 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2013 | 3125 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2007 | 202 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8391 | 0.010 |
Why?
| | Aged | 2 | 2019 | 26432 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2008 | 1298 | 0.010 |
Why?
| | RNA, Untranslated | 1 | 2007 | 125 | 0.010 |
Why?
| | Internet | 1 | 2010 | 660 | 0.010 |
Why?
| | DNA Replication | 1 | 2007 | 248 | 0.010 |
Why?
| | Prevalence | 1 | 2012 | 2861 | 0.010 |
Why?
| | Databases, Factual | 1 | 2010 | 1493 | 0.010 |
Why?
| | Genome | 1 | 2007 | 307 | 0.010 |
Why?
| | DNA, Plant | 1 | 2004 | 17 | 0.010 |
Why?
| | Inbreeding | 1 | 2004 | 20 | 0.010 |
Why?
| | Biomarkers | 1 | 2015 | 4340 | 0.010 |
Why?
| | Genes, Plant | 1 | 2004 | 46 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2009 | 887 | 0.010 |
Why?
| | Fibroblasts | 1 | 2009 | 1034 | 0.010 |
Why?
| | Population Density | 1 | 2004 | 91 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1574 | 0.010 |
Why?
| | Protein Binding | 1 | 2007 | 2244 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2009 | 2012 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2675 | 0.010 |
Why?
| | Transcription Factors | 1 | 2007 | 1730 | 0.010 |
Why?
|
|
Stranger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|